Literature DB >> 30835854

Isolation of Desulfovibrio spp. from human gut microbiota using a next-generation sequencing directed culture method.

Y-R Chen1,2, L-Z Zhou3, S-T Fang1, H-Y Long1, J-Y Chen1, G-X Zhang1.   

Abstract

Desulfovibrio spp. is predominant member of sulphate-reducing bacteria in human gut microbiota. Previous studies indicated that the isolation of Desulfovibrio strains from human faecal samples is very important to study the roles of human intestinal Desulfovibrio spp. in maintaining healthy states or causing diseases, as well as defining their biological characteristics. However, there are very few reports describing the isolation of Desulfovibrio spp. from human faecal samples. In this study, faecal samples were inoculated into various media containing different components. The enriched culture communities were identified using 16S rRNA gene high-throughput sequencing analysis, enabling us to identify the specific components that enable the enrichment of Desulfovibrio. Using this information, we developed five specific media and identified an effective enrichment medium that produced the highest relative abundance of Desulfovibrio in communities cultured from four faecal samples (26·5, 73·5, 44·7 and 77·6% respectively). In addition, the major non-Desulfovibrio genera were identified. Finally, three species of Desulfovibrio, D. desulfuricans, D. piger and D. legallii were isolated, representing the first time that has D. legallii been isolated from a human gastrointestinal source. SIGNIFICANCE AND IMPACT OF THE STUDY: ost of the human intestinal bacteria have not been cultured because of lack of appropriate culture method and appropriate media. Desulfovibrio spp. is associated with several clinical conditions like inflammatory bowel disease, but until now there are very few reports describing the isolation of Desulfovibrio spp. from human faecal samples. In this study, 16S rRNA gene high-throughput sequencing analysis was applied to screen appropriate enrichment media and selective cultivation of Desulfovibrio. This sequencing-based directed culture method described here can be used for the selective cultivation of gut bacteria of interest.
© 2019 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990Desulfovibriozzm321990; 16S rRNA gene high-throughput sequencing; culture; human gut; media

Mesh:

Substances:

Year:  2019        PMID: 30835854     DOI: 10.1111/lam.13149

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  7 in total

1.  The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice.

Authors:  Valentina Cossiga; Vincenzo Lembo; Cecilia Nigro; Paola Mirra; Claudia Miele; Valeria D'Argenio; Alessia Leone; Giovanna Mazzone; Iolanda Veneruso; Maria Guido; Francesco Beguinot; Nicola Caporaso; Filomena Morisco
Journal:  Nutrients       Date:  2021-04-13       Impact factor: 5.717

2.  Relationships of sleep disturbance, intestinal microbiota, and postoperative pain in breast cancer patients: a prospective observational study.

Authors:  Zhi-Wen Yao; Bing-Cheng Zhao; Xiao Yang; Shao-Hui Lei; Yu-Mei Jiang; Ke-Xuan Liu
Journal:  Sleep Breath       Date:  2020-11-19       Impact factor: 2.816

Review 3.  Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis.

Authors:  Pan Chen; Xiangqi Tang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

4.  Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.

Authors:  Giorgia Renga; Emilia Nunzi; Marilena Pariano; Matteo Puccetti; Marina Maria Bellet; Giuseppe Pieraccini; Fiorella D'Onofrio; Ilaria Santarelli; Claudia Stincardini; Franco Aversa; Francesca Riuzzi; Cinzia Antognelli; Marco Gargaro; Oxana Bereshchenko; Maurizio Ricci; Stefano Giovagnoli; Luigina Romani; Claudio Costantini
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 13.751

5.  Effect of Electroacupuncture at Zusanli (ST36) on Intestinal Microbiota in Rats With Chronic Atrophic Gastritis.

Authors:  Wanyi Huang; Yuenming Yau; Jingru Zhu; Yingjie Wang; Zhipeng Dai; Huijuan Gan; Linchao Qian; Zongbao Yang
Journal:  Front Genet       Date:  2022-02-23       Impact factor: 4.599

6.  Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.

Authors:  Pieter de Groot; Tanja Nikolic; Silvia Pellegrini; Valeria Sordi; Sultan Imangaliyev; Elena Rampanelli; Nordin Hanssen; Ilias Attaye; Guido Bakker; Gaby Duinkerken; Antoinette Joosten; Andrei Prodan; Evgeni Levin; Han Levels; Bartjan Potter van Loon; Arianne van Bon; Catherina Brouwer; Sytze van Dam; Suat Simsek; Daniel van Raalte; Frank Stam; Victor Gerdes; Roel Hoogma; Martin Diekman; Martin Gerding; Cees Rustemeijer; Bernadette de Bakker; Joost Hoekstra; Aeilko Zwinderman; Jacques Bergman; Frits Holleman; Lorenzo Piemonti; Willem De Vos; Bart Roep; Max Nieuwdorp
Journal:  Gut       Date:  2020-10-26       Impact factor: 23.059

7.  Nutrient Intake and Gut Microbial Genera Changes after a 4-Week Placebo Controlled Galacto-Oligosaccharides Intervention in Young Females.

Authors:  Nicola Johnstone; Susannah Dart; Paul Knytl; Arjen Nauta; Kathryn Hart; Kathrin Cohen Kadosh
Journal:  Nutrients       Date:  2021-12-08       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.